The mutation KCNJ3 p.N496H is associated with an elevated risk of AF development, while mutations KCNJ5 p.G387R and KCNJ3 p.F85L are considered either neutral or potentially beneficial with respect to disease progression. This evidence concerns the gene KCNJ3 and atrial fibrillation.